Navigation Links
Vanda Presents Phase III Iloperidone Efficacy Data
Date:12/12/2007

Findings also demonstrate favorable safety and tolerability profile

ROCKVILLE, Md., Dec. 12 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that data from four Phase III efficacy and safety trials demonstrate that iloperidone, an investigational atypical antipsychotic, is associated with significantly greater improvements in the symptoms of schizophrenia versus placebo and has a favorable safety and tolerability profile. These results were included as part of the recently filed New Drug Application (NDA) for iloperidone and were presented for the first time this week at a major psychiatric congress. Posters containing the data presented will be posted on Vanda's Web site, http://www.vandapharma.com, on Thursday, December 13, 2007. The U.S. Food and Drug Administration (FDA) accepted the NDA submitted by Vanda for marketing approval on November 26, 2007.

The Phase III study conducted by Vanda evaluated the efficacy of iloperidone versus placebo in patients with schizophrenia. The study was a randomized, double-blind, placebo-controlled, multi-center, four-week inpatient study that enrolled 604 patients. Following fixed-dose titration, inpatients were randomized to receive iloperidone at 24 mg/day, ziprasidone at 160 mg/day, or placebo. Patients treated with iloperidone had significantly greater improvements in Positive and Negative Syndrome Scale-Total (PANSS-T) scores than those on placebo and had PANSS-T improvement comparable to ziprasidone.

"There is a great need for new treatment options for schizophrenia, particularly as patients often discontinue treatment due to efficacy and tolerability issues, as seen in the NIMH-funded
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-seven. ... the Company, commented, "We believe our current pipeline of ...
(Date:6/30/2015)... Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX ... the development and commercialization of Locilex® (pexiganan cream ... announced underwritten public offering of 1,480,000 shares of ... option in full to purchase an additional 222,000 ... proceeds to Dipexium are expected to be approximately ...
(Date:6/30/2015)... 2015  Today, the National Mobility Equipment Dealers Association ... Mobility Awareness Month Local Heroes Contest on National TV. ... that received 1.3 million votes. The sponsors for the ... Mobility , and Valley Honda Dealers , with ... Vantage Mobility International (VMI) and ElDorado Mobility ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... Aug. 2 Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused ... again been selected by leading dental industry magazine Dentistry Today as one ... 24th annual competition were published in the July issue.   , ... OraVerse is the first ...
... , ST. LOUIS ,  Aug. 2 K-V Pharmaceutical ... received notification from the New York Stock Exchange ("NYSE") on ... quantitative continued listing standards.  The NYSE informed the Company that ... criteria for the average closing price of a NYSE security ...
Cached Medicine Technology:OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 2K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 5K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 6K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 7K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 8K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 9
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June 15th ... grant to study how sensory stimuli can be used to “decrease children’s anxiety and ... for children with autism, will compare patient experience in a “typical dental environment” with ...
(Date:6/30/2015)... Denver,CO (PRWEB) , ... June 30, 2015 , ... ... the 26th Annual Alzheimer's Association of Colorado's Education Symposium on November 9, 2015 ... Association is honored to host a conversation with Kim and Ashley Campbell, the ...
(Date:6/30/2015)... Orange, CA (PRWEB) , ... June 30, 2015 ... ... to the community. , Eleven physicians from Allied’s Fullerton division volunteered to help ... 8th annual Super Surgery Saturday, March 21, at St. Jude Medical Center. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... centers are partnering to improve access to cancer prevention, screening and care for ... (LCC) have announced an affiliation that will see Roswell Park faculty providing clinical ...
(Date:6/30/2015)... ... 2015 , ... Board certified otolaryngologist Dr. Marcelo B. Antunes ... , Dr. Antunes is a fellowship trained facial plastic surgeon with ... to performing cosmetic and reconstructive surgery on the face, he enjoys treating patients ...
Breaking Medicine News(10 mins):Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3
... food costs, many families are,economizing on groceries but one thing ... cents per 8-ounce glass, on a gallon basis, milk offers,more ... the,supermarket -- proving key vitamins and minerals like calcium and ... moms don,t cut milk from,their grocery lists, the National got ...
... costs, many,families are economizing on groceries but one thing ... 25 cents per 8-ounce glass, on a gallon basis, ... beverage option in the,supermarket -- proving key vitamins and ... the entire family. To ensure moms don,t cut milk ...
... First DataBank, a leading,provider of integrated drug ... announced the company,s drug data has been,integrated into ... secure, Web-based platform that,facilitates on-demand, real-time Online and ... , Through ...
... Level of Usage Restrictions, According to a New Report ... , MALVERN, Penn. and WALTHAM, Mass.,Dec. 15 ... that the most important factors that influence antibiotic selection ... agent,s availability in intravenous (IV) formulation, activity against Pseudomonas ...
... Developed last year in response to,corporate America,s need for comprehensive EDI ... with a bigger, better and brand new,schedule of training for 2009. ... Schedule , Pre-registration for the ... decisively shown the need for as many sessions as possible;,consequently, EDI ...
... Life magazine, the upscale,men,s magazine from health and fitness publisher ... the best computer-based cognitive,training program. Best Life surveyed the ... and picked The Brain Fitness,Program as number one -- the ... 5 points. , The ...
Cached Medicine News:Health News:Milk is One Beverage Houston Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Houston Can't Afford to Keep Off the Grocery List 3Health News:Milk is One Beverage Birmingham Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Birmingham Can't Afford to Keep Off the Grocery List 3Health News:American Well Selects First DataBank's Drug Data for Use in Online Physician-Patient Care Consultations 2Health News:American Well Selects First DataBank's Drug Data for Use in Online Physician-Patient Care Consultations 3Health News:Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity 2Health News:Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity 3Health News:Fresh from Its 2008 Success, EDI Training Academy Expands into 2009 with 20 New Seminars and an EDI Health Care Best Practices Course 2Health News:Posit Science is Best in Brain Fitness Says Best Life 2
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: